Advertisment
|
|
DIA News Roundup
Oracle Health Sciences announces Clinical One, its cloud-based eClinical platform being built from the ground-up to address the needs of the entire drug development lifecycle. Oracle also launched its first capability on the new platform, Oracle Health Sciences Clinical One Randomization and Supplies Management Cloud Service, which features an intuitive user interface, enabling clinical teams to design, validate and deploy a study more efficiently.
| advertisment
Text Ad - 1 heading
Text Ad content goes here
Learn more |
Clinical trial recruitment, engagement, and technology company BBK Worldwide (BBK), has released results of a data analysis across a broad spectrum of trials. The findings confirm the premise that alleviating site staff of many of the mechanical aspects of clinical trial patient management allows more time for personal patient care, creating an enhanced clinical trial experience for patients and site staff alike.
| advertisment
Text Ad - 2 heading
Text Ad content goes here
Learn more |
The Veeva 2017 Unified Clinical Operations Survey found that nearly all respondents (99%) report at least one major challenge with their clinical applications, most often stemming from application and process silos where 69% cite integrating multiple applications as their biggest issue. Most say (76%) unifying their applications will drive improvements in three or more important areas, including study speed and quality.
| advertisment
Text Ad - 4 heading
Text Ad content goes here
Learn more |
Bioclinica’s Clean Patient Optics™ is a fully-validated clinical trial software solution that provides insights to patient data to improve data cleaning for accelerated database lock and clinical trial timelines.
| advertisment
Text Ad - 6 heading
Text Ad content goes here
Learn more |
DIA executives discuss the regulatory trends on tap for discussion at the meeting this week.
|
|
|
advertisment
|
|
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers » |
|
|
| advertisment
Text Ad - 3 heading
Text Ad content goes here
Learn more |
Blog Posts
Dr. Jonathan Rowe, Executive Director and Head of Clinical Development Quality Performance and Risk Management, at Pfizer discusses how they are leveraging predictive models to manage study risk and quality.
| advertisment
Text Ad - 5 heading
Text Ad content goes here
Learn more |
Bioclinica’s Clean Patient Optics™ is a fully-validated clinical trial software solution that provides insights to patient data to improve data cleaning for accelerated database lock and clinical trial timelines.
|
|
Other News
LabCorp announced that its Covance Drug Development business will open a companion diagnostics lab in Morrisville, North Carolina. The facility also includes a genomics and molecular pathology lab to support clinical trials and diagnostic testing development, and houses manufacturing facilities for diagnostics materials and testing components.
| advertisment
Text Ad - 7 heading
Text Ad content goes here
Learn more |
In anticipation of relocating, the EMA has started on the re-distribution of the workload relating to the evaluation and monitoring of medicines to ensure the quality of EMAs scientific assessments and compliance with legal timelines
Additionally, the EMA announced that the EU clinical trial portal and database’s go-live date has been postponed, due to technical issues with the IT systems.
| advertisment
Text Ad - 9 heading
Text Ad content goes here
Learn more |
|
|
Articles
This study looks at in-office conversations earlier in the patient journey toward a clinical trial, before suitable trial options have been identified or patient eligibility for a study has been established. These early conversations set the stage for patients’ understanding of and receptivity toward enrolling in a clinical trial in the future.
| advertisment
Text Ad - 8 heading
Text Ad content goes here
Learn more |
This study looks at in-office conversations earlier in the patient journey toward a clinical trial, before suitable trial options have been identified or patient eligibility for a study has been established. These early conversations set the stage for patients’ understanding of and receptivity toward enrolling in a clinical trial in the future.
| advertisment
Text Ad - 10 heading
Text Ad content goes here
Learn more |
|
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription |
|
|
|
|
|
